Duopharma Biotech Bhd Tangible Net Worth Ratio
Duopharma Biotech Bhd tangible net worth ratio. Duopharma Biotech Bhd (7148) has a Tangible Net Worth Ratio of 95.6% as of June 2026. This metric is calculated by deducting intangible assets (RM34.89 Million) from net assets (RM786.14 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 7148 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Duopharma Biotech Bhd (2006–2025)
Tangible net worth ratio of Duopharma Biotech Bhd from 2006 to 2025. This chart shows how Duopharma Biotech Bhd's Tangible Net Worth Ratio has changed across 20 annual periods from 2006 to 2025. As of June 2026, the ratio stands at 95.6%, reflecting net assets of RM786.14 Million with intangible assets of RM34.89 Million MYR. Check Duopharma Biotech Bhd (7148) strategic asset index to assess the company's strategic physical and investment asset allocation.
Duopharma Biotech Bhd Tangible Net Worth Ratio by Year (2006–2025)
Duopharma Biotech Bhd tangible net worth ratio by year from 2006 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Duopharma Biotech Bhd from 2006 to 2025, covering 20 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 7148 market cap.
| Year | Tangible NW Ratio | Net Assets (MYR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 95.1% | RM757.62 Million | RM36.88 Million | RM1.45 Billion | ▲ +1.5 pp |
| 2024 | 93.7% | RM709.15 Million | RM44.87 Million | RM1.38 Billion | ▼ -0.7 pp |
| 2023 | 94.4% | RM687.12 Million | RM38.80 Million | RM1.35 Billion | ▲ +1.1 pp |
| 2022 | 93.3% | RM655.22 Million | RM43.98 Million | RM1.22 Billion | ▼ -0.4 pp |
| 2021 | 93.7% | RM624.00 Million | RM39.52 Million | RM1.16 Billion | ▼ -0.9 pp |
| 2020 | 94.6% | RM643.82 Million | RM35.07 Million | RM1.06 Billion | ▼ -0.1 pp |
| 2019 | 94.7% | RM529.75 Million | RM28.11 Million | RM919.80 Million | ▼ -1.3 pp |
| 2018 | 96.0% | RM481.04 Million | RM19.40 Million | RM836.38 Million | ▼ -0.7 pp |
| 2017 | 96.6% | RM479.87 Million | RM16.23 Million | RM705.24 Million | ▼ -0.6 pp |
| 2016 | 97.2% | RM454.52 Million | RM12.73 Million | RM661.46 Million | ▼ -0.8 pp |
| 2015 | 98.0% | RM449.72 Million | RM8.81 Million | RM633.45 Million | ▼ -0.4 pp |
| 2014 | 98.4% | RM193.63 Million | RM3.06 Million | RM222.48 Million | ▼ -1.0 pp |
| 2013 | 99.4% | RM182.65 Million | RM1.06 Million | RM205.65 Million | ▼ -0.6 pp |
| 2012 | 100.0% | RM170.50 Million | RM0.00 | RM198.03 Million | ▲ +0.0 pp |
| 2011 | 100.0% | RM164.44 Million | RM0.00 | RM197.52 Million | ▲ +0.0 pp |
| 2010 | 100.0% | RM157.87 Million | RM0.00 | RM196.48 Million | ▲ +0.0 pp |
| 2009 | 100.0% | RM142.74 Million | RM0.00 | RM173.36 Million | ▲ +0.0 pp |
| 2008 | 100.0% | RM130.55 Million | RM0.00 | RM150.38 Million | ▲ +0.0 pp |
| 2007 | 100.0% | RM114.21 Million | RM0.00 | RM127.33 Million | ▲ +0.0 pp |
| 2006 | 100.0% | RM145.43 Million | RM0.00 | RM159.01 Million | — |